Treating depression in patients with heart failure: what is (not) recommended?-Reference-Cited by-同舟云学术

Treating depression in patients with heart failure: what is (not) recommended?

Published:2022-05-05 Issue:16 Volume:29 Page:2137-2139
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:

Author:

Herrmann-Lingen Christoph¹^ORCID

Affiliation:

1. Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Centre and German Centre for Cardiovascular Research (DZHK) , Von-Siebold-Str. 5, D-37075 Göttingen , Germany

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

https://academic.oup.com/eurjpc/advance-article-pdf/doi/10.1093/eurjpc/zwac092/43971077/zwac092.pdf

Reference11 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

2. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice;Visseren;Eur Heart J,2021

3. Effect of antidepressants on death in patients with heart failure: a systematic review and meta-analysis;He;Heart Fail Rev,2020

4. Commentary concerning treatment of depression in patients with heart failure according to 2021 ESC guidelines on cardiovascular disease prevention in clinical practice;Wilkowska;Eur J Prevent Cardiol,2022

5. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial;O’Connor;J Am Coll Cardiol,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global research trends on psychosocial rehabilitation in patients with cardiovascular diseases: A bibliometric analysis using CiteSpace;Cognition, Brain, Behavior. An interdisciplinary journal;2022-12-20